Background/Objectives: Cancer is the second most common cause of death in Poland, responsible for 26.7% of deaths in 2023. Our aim was to estimate total direct and indirect costs of cancer in Poland. Methods: We acquired epidemiological data from the System Analysis and Implementation Database provided Polish Ministry of Health. For estimating the direct costs of medical procedures and chemotherapy, we used statistics of homogeneous groups of patients provided by the Polish National Health Fund. For analyzing the indirect costs in the field of absenteeism we acquired data from Statistical Portal of Polish Social Insurance Institution. Results: The total direct costs of treatment for cancer in the adult population in the period 2021–2023 to be equal to USD 192,935,858, taking purchasing power parity of Polish currency into account. This was equal to 0.00394% of General Domestic Product. The costs associated with absenteeism were equal to USD 3,103,526,321, which was equal to 0.063% of GDP. The sum of Years of Potential Life Lost was equal to 930,962 and the sum of Years of Potential Productive Life Lost was equal to 363,511. Cancer morbidity and incidence in the period 2021–2023 increased by 1.3%. Mortality increased by 2.1%. The total cost of medical services relative to GDP in 2022 was lower than in 2021; in 2023, however, it was higher than both in 2021 and 2022. The cost of chemotherapy, both in absolute numbers and relative to GDP, was significantly lower in 2022 than in 2021. Conclusions: In 2023, the cost was higher than in 2021 and in 2022. The costs of absenteeism in three consecutive years increased. Years of Potential Life Lost and Years of Potential Productive Life Lost due to cancer increased substantially in the period 2021–2023, both for males and for females, in all three age groups.

Celem artykułu jest analiza znaczenia dowodu z opinii biegłego w sprawach medycznych w postępowaniu cywilnym oraz ocena granic swobodnej oceny dowodów przez sąd wobec konieczności posługiwania się wiedzą specjalistyczną. Postawiono tezę, że opinia biegłego stanowi istotny dowód w procesach o w sprawach medycznych w postępowaniu cywilnym. W pracy zastosowano metodę dogmatyczno-prawną, opartą na analizie przepisów Kodeksu postępowania cywilnego, Kodeksu cywilnego, a także metodę analizy orzecznictwa sądów powszechnych i Sądu Najwyższego. Wnioski prowadzą do stwierdzenia, że opinie biegłych mają istotne znaczenie dla spraw medycznych w postępowaniu cywilnym– nie tylko pomagają sądom przy prawidłowej rekonstrukcji stanu faktycznego, ale stanowią istotny czynnik wpływający na merytoryczną zgodność rozstrzygnięć z obiektywnymi realiami spraw medycznych.

Background/Objectives: Personal values shape appraisal of stress and life satisfaction. We examined the relationship between perceived stress and life satisfaction among uniformed personnel in outpatient mental health care, and the role of a personal values hierarchy in this context. Methods: Cross-sectional study of 183 uniformed personnel (34 females, 149 males, age 30–66 years, M = 44.72, SD = 5.84) diagnosed with bodily distress disorder or post-traumatic stress disorder at a mental health clinic. Participants completed standardized questionnaires assessing perceived stress, satisfaction with life, coping styles, and personal values. For the Personal Value List, each value not selected by a participant was coded as 0 to avoid missing data; scores regarding symbols of happiness were not used. Reliability was evaluated via repeated measurement; two parts of a key instrument showed test–retest correlations of approximately 0.78 and 0.76. For assessing statistical significance, the bootstrap method was used (1000 resamples). Analyses were conducted in jamovi 2.3.28 using snowLatent (latent profile analysis) and medmod 1.1.0 (moderation analysis). Results: Perceived stress was negatively associated with satisfaction with life (B = −0.36, 95% CI [−0.48; −0.24], p < 0.001). Latent profile analysis extracted two personal values hierarchy profiles (AIC = 4237; BIC = 4587). Profile membership was not a significant predictor of satisfaction with life (p = 0.595) and did not moderate the relationship between perceived stress and satisfaction with life (p = 0.907). Distraction seeking was significantly higher in profile 1 (p = 0.010). Conclusions: In treated uniformed personnel, higher perceived stress is linked to lower life satisfaction. The personal values hierarchy did not moderate this relationship and was not associated with satisfaction with life; however, the personal values hierarchy was related to coping, specifically distraction seeking.

Background/Objectives: Public health programmes for older adults aim to reduce hospital admissions and improve health outcomes. However, the effects of these programmes on the length of hospital stays for seniors remain unclear. This study aimed to examine the link between the number and type of public health initiatives implemented between 2017 and 2018, and the number of hospitalisations, as well as the duration of hospital stays in 2019 and 2020, among seniors with heart, digestive, and musculoskeletal diseases. Methods: A correlation analysis was conducted to explore the relationship between the number of public health programmes and activities, and the number and length of hospitalisations among older adults. Statistical significance was set at p < 0.05 and p < 0.01. Results: The analysis revealed positive correlations between the number of completed public health tasks and the length of hospital stay across the three disease groups. For heart disease, hospital stay length was correlated with the total number of programmes (r = 0.501, p < 0.05) and those specifically supporting medical services (r = 0.574, p < 0.05). In cases of digestive diseases, correlations were observed with the overall number of programmes (r = 0.623, p < 0.01), as well as programmes in the “general” category and ones supporting medical services (r = 0.544–0.601, p < 0.05). Regarding musculoskeletal diseases, the strongest correlation occurred with programmes that support medical services (r = 0.700, p < 0.01). Conclusions: Our results indicate that increased public health interventions may be associated with longer hospital stays among seniors, likely reflecting the emergence of more complex health needs and increased diagnostic intensity. At the same time, analysis based on ecological data does not allow for the establishment of causal relationships, emphasizing the need for further, more advanced research that controls for confounding factors.

Background: Melanoma treatment encompasses surgery, chemotherapy, radiotherapy, immunotherapy, and targeted therapy. Despite declining mortality due to therapeutic advances, increasing incidence underscores the growing importance of cost-effectiveness analyses. The integration of cost-effectiveness evaluation with Bayesian meta-analysis and meta-regression may enhance the synthesis of heterogeneous evidence. Methods: A systematic literature review was conducted to identify studies reporting quality-adjusted life years (QALYs) and direct treatment costs for melanoma in PubMed, MEDLINE, and MEDLINE Ultimate. Bayesian meta-analysis with non-informative priors was applied to derive pooled estimates and quantify uncertainty. Results: A total of 272 studies were identified, of which only a limited subset met the inclusion criteria. The studies exhibited substantial heterogeneity in treatments, populations, time horizons, perspectives, and costs. Meta-analysis based on the effects provided in one study showed that chemotherapy demonstrated lower effectiveness, as measured by QALYs, compared with treatment sequences such as Anti-PD1 → Bi-TT and Bi-TT → Anti-PD1 in both BRAF-mutated and wild-type populations. Lower costs were associated with chemotherapy, ipilimumab, and Anti-PD1 relative to combination and sequential regimens. Meta-analysis based on the effects provided in another study showed that treatment costs increased with advancing disease stage (≥IIIA) and exhibited greater variability in advanced melanoma. Conclusion: The combined methodological approach enhances the robustness and comparability of estimates. The observed variability in both clinical effectiveness and costs, across treatment strategies and disease stages, has important implications for healthcare decision-making and resource allocation.